The status and related causes of off-label using of bevacizumab in the treatment of neovascular age-related macular degeneration in China and abroad

XUE Yi-fei; LI Guang-yao; ZHANG Chao

doi:10.3969/j.issn.1003-3734.2022.08.016

Home>Articles>The status and related causes of off-label using of bevacizumab in the treatment of neovascular age-related macular degeneration in China and abroad

DOI: 10.3969/j.issn.1003-3734.2022.08.016

The status and related causes of off-label using of bevacizumab in the treatment of neovascular age-related macular degeneration in China and abroad

XUE Yi-fei

LI Guang-yao

ZHANG Chao

Machine-generated Keywords：

Publication Date：2022-04-30

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 813-818 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2022,31(8)